Microfluidic Bead Manufacturing via Cooling and Desolvation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for manufacturing polymeric beads for controlled release of pharmaceutically active agents often result in beads with a broad size distribution and residual solvent, due to techniques like stirring, static mixing, dripping, or spray formation, which can lead to inconsistent drug delivery and safety concerns.
Innovation Solution
A microfluidic device is used to create solid beads by combining a carrier fluid and a functional fluid containing a polymer, where the functional fluid droplets are cooled to solidify and then treated with an anti-solvent in a desolvating conduit, minimizing solvent retention and achieving a uniform bead size distribution.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional methods (stirring, static mixing, dripping, spray formation) are used to manufacture polymeric beads, then the manufacturing process is simple and easy to operate, but the beads exhibit broad size distribution and contain residual solvent
Solution Approach 1:
The manufacturing process is divided into distinct functional segments: a junction region for droplet formation, a cooling conduit for solidification, and a desolvating conduit for solvent removal. This segmentation allows each stage to be optimized independently, achieving narrow bead size distribution while systematically removing residual solvent through the anti-solvent injection system.
Solution Approach 2:
An anti-solvent is introduced as an intermediary substance in the desolvating conduit to facilitate solvent removal from the beads. The anti-solvent acts as a mediator that extracts the residual solvent from the bead matrix without dissolving the polymer, thereby reducing residual solvent content while maintaining bead integrity and narrow size distribution.
2Manufacturing precision
If conventional droplet generation methods are used, then the device structure is simple, but the beads contain relatively large amounts of residual solvent
Solution Approach 1:
The beads undergo preliminary cooling and solidification in the cooling conduit before entering the desolvating conduit. This preliminary action solidifies the bead structure, preventing deformation during subsequent solvent removal, and prepares the beads for efficient anti-solvent treatment that minimizes residual solvent content.
Solution Approach 2:
The anti-solvent serves as an intermediary agent that selectively removes residual solvent from the beads through mass transfer. By injecting the anti-solvent into the desolvating conduit, the system achieves thorough solvent extraction while maintaining bead morphology, thereby minimizing residual solvent content without requiring overly complex device structures.
3Manufacturing precision
If conventional mixing or dripping methods are used, then the process is continuous and productive, but the beads exhibit broad size distribution affecting drug delivery consistency
Solution Approach 1:
The microfluidic device maintains continuous flow of functional fluid through the junction region, cooling conduit, and desolvating conduit, enabling uninterrupted droplet formation, solidification, and solvent removal. This continuous operation ensures high manufacturing efficiency while the controlled microfluidic environment guarantees narrow bead size distribution for consistent drug delivery.
Solution Approach 2:
The conventional mechanical mixing or dripping systems are replaced with a microfluidic-based system that uses controlled fluid flow and pressure gradients to generate monodisperse droplets. This substitution eliminates the broad size distribution associated with mechanical methods while maintaining continuous production, thereby achieving both high manufacturing precision and productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microfluidic device produces beads with a narrow size distribution and minimal residual solvent, enhancing the consistency and effectiveness of drug delivery, including controlled release and targeting capabilities.
Implementation Method 1
a cooler operable to cool fluid in the cooling conduit
Implementation Method 2
The droplets may, for example, be frozen or in the form of a gel
Implementation Method 3
a desolvating conduit arranged for receiving fluid from the cooling conduit, the device being provided with an anti-solvent inlet for introducing an anti-solvent into the desolvating conduit
Data Source
AI summary
A method of making solid beads is disclosed, said method comprising: (i) providing a microfluidic device comprising a carrier fluid conduit and a functional fluid conduit which meet at a junction region; (ii) providing a laminar flow of a functional fluid comprising a solvent and a solute along the functional fluid conduit and providing a laminar flow of a carrier fluid along the carrier fluid conduit so as to form droplets of functional fluid in a flow of carrier fluid; (iii) cooling the segments of functional fluid in a conduit of the microfluidic device to form cooled (preferably frozen) droplets; and (iv) providing a liquid into intimate admixture with the cooled droplets so as to cause said solvent to exit said cooled droplets, thus forming solid beads. A microfluidic device for use in such a method is also disclosed.